Background Second generation drug-eluting stents were developed to improve the safety and efficacy of first generation stents. So far, limited long term randomized data exist comparing the second gene
Supplemental material, sj-xlsx-3-pch-10.1177_21501351221129194 for Outcomes of Treatment for Infective Endocarditis Following Transcatheter Pulmonary Valve Replacement by J. Chancellor Fox, Horacio G.
This meta-analysis aimed to evaluate the incidence and clinical outcomes of device-related thrombosis (DRT) after plug-type versus cover-type left atrial appendage closure (LAAC)
